Claros Diagnostics is a medical device company developing low-cost, rapid, point-of-care diagnostics. Using proprietary chemistry and microfluidic technology from Professor George Whitesides’ lab at Harvard University, the company’s initial product will be a handheld urological cancer diagnostic testing system for point-of-care use. Claros is also exploring ways to use its platform to develop affordable, appropriate diagnostics for global health applications.
Location: Woburn, Massachusetts
Commons Capital’s co-investors include:
Oxford Bioscience Partners, BioVentures Investors and Accelerated Technologies Partners
Website: www.clarosdx.com
